Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.
CONCLUSION: MSP participants with invasive breast cancer can generally be treated with less intensive surgical and systemic therapy than non-participants, even if interval cancers are also taken into account. Future studies should also investigate quality of life after a diagnosis of invasive carcinoma in screening participants.
PMID: 30149831 [PubMed - in process]
Source: Deutsches Arzteblatt International - Category: General Medicine Tags: Dtsch Arztebl Int Source Type: research
More News: Biology | Breast Cancer | Breast Carcinoma | Breast Conservation Surgery | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | General Medicine | Germany Health | Mammography | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Women